AGL 38.45 Decreased By ▼ -0.03 (-0.08%)
AIRLINK 197.00 Decreased By ▼ -6.02 (-2.97%)
BOP 10.03 Decreased By ▼ -0.14 (-1.38%)
CNERGY 6.32 Decreased By ▼ -0.22 (-3.36%)
DCL 9.31 Decreased By ▼ -0.27 (-2.82%)
DFML 39.30 Decreased By ▼ -0.72 (-1.8%)
DGKC 98.00 Decreased By ▼ -0.08 (-0.08%)
FCCL 35.50 Increased By ▲ 0.54 (1.54%)
FFBL 86.21 Decreased By ▼ -0.22 (-0.25%)
FFL 13.65 Decreased By ▼ -0.25 (-1.8%)
HUBC 130.30 Decreased By ▼ -1.27 (-0.97%)
HUMNL 13.80 Decreased By ▼ -0.22 (-1.57%)
KEL 5.28 Decreased By ▼ -0.33 (-5.88%)
KOSM 7.42 Increased By ▲ 0.15 (2.06%)
MLCF 45.20 Decreased By ▼ -0.39 (-0.86%)
NBP 61.25 Decreased By ▼ -5.13 (-7.73%)
OGDC 216.02 Decreased By ▼ -4.74 (-2.15%)
PAEL 39.29 Increased By ▲ 0.81 (2.1%)
PIBTL 8.57 Decreased By ▼ -0.34 (-3.82%)
PPL 194.00 Decreased By ▼ -3.88 (-1.96%)
PRL 39.06 Increased By ▲ 0.03 (0.08%)
PTC 25.65 Increased By ▲ 0.18 (0.71%)
SEARL 104.10 Increased By ▲ 1.05 (1.02%)
TELE 8.69 Decreased By ▼ -0.33 (-3.66%)
TOMCL 36.03 Decreased By ▼ -0.38 (-1.04%)
TPLP 13.85 Increased By ▲ 0.10 (0.73%)
TREET 24.76 Decreased By ▼ -0.36 (-1.43%)
TRG 56.90 Decreased By ▼ -1.14 (-1.96%)
UNITY 33.15 Decreased By ▼ -0.52 (-1.54%)
WTL 1.63 Decreased By ▼ -0.08 (-4.68%)
BR100 11,744 Decreased By -146.2 (-1.23%)
BR30 36,569 Decreased By -787.7 (-2.11%)
KSE100 109,663 Decreased By -1407.8 (-1.27%)
KSE30 34,470 Decreased By -439 (-1.26%)

THE HAGUE: Studies of pregnant women found the two most widely used Covid vaccines pose no risk to mothers or babies, the EU's drug regulator said on Tuesday.

Research involving some 65,000 women showed "growing evidence" that the Pfizer and Moderna jabs did not cause pregnancy complications, the European Medicines Agency (EMA) said.

The shots also provided increased protection against hospitalisation and death, particularly in late pregnancy, said the watchdog.

"The review did not find any sign of an increased risk of pregnancy complications, miscarriages, preterm births or adverse effects in the unborn babies following mRNA Covid-19 vaccination," the EMA said in a statement.

Pfizer and Moderna both use new Messenger RNA tecnology.

Covax delivers one billionth Covid vaccine dose

The Amsterdam-based regulator said it had carried out a "detailed review of several studies" involving around 65,000 pregnancies at different stages.

"The review of real world evidence suggests that the benefits of receiving mRNA Covid-19 vaccines during pregnancy outweighs any possible risks for expectant mothers and unborn babies," it said.

Pregnancy itself had been associated with a higher risk of severe Covid in the second and third trimesters, so expectant mothers should get vaccinated, it said.

The EMA said it would now review data for the other vaccines it has authorised "as they become available".

Comments

Comments are closed.